At Infiniti, we help our clients build capabilities and seize new opportunities while addressing the evolving challenges faced by the pharmaceutical industry. In face of the global economic slowdown, growing demand for increased life expectancy, and constant need for innovation across the pharma industry, new players must build capabilities, and expand into new products and geographies.
Our customized pharm intelligence solutions, crafted by our team of top industry experts, reflect the newest pharmaceutical market trends, future directions and unexplored avenues across the pharmaceutical industry. We provide practical solutions that can deliver repeatable and sustainable results for our pharma clients.
Our pharmaceutical industry analysis combines surveys, interviews, primary and secondary research methodologies, and pharma competitive intelligence to offer a holistic approach to tackling business challenges faced by our clients in the pharmaceutical industry. Our extensive experience and global reach make us well positioned to help our clients make the most of new opportunities. Infiniti’s industry experts also provide pharmaceutical market opportunity analysis and customized research based on a vast network of pharma intelligence from industry associations, manufacturers, distributors, and end-users to equip clients with precise information.
Every hour, COPD is estimated to kill over 250 people worldwide. The WHO estimates that COPD will be the third leading cause of death globally by 2030.
More like a ‘smoker’s cough,’ the chronic obstructive pulmonary disease (COPD) is a life-threatening lung disease that interferes with normal breathing. A recent study shows that it is the only major cause of death whose prevalence is on the increase and is envisaged to be the third leading cause of death globally by 2030 – exceeded only by heart diseases and stroke. This recent increase in the incidence of COPD in regions like Europe has subsequently accelerated the need for treatment options like Non-Invasive Ventilation (NIV), which help patients breathe through a machine that is attached to a mask. Though similar to a nebulizer, NIV is usually used when patients have a severe flare-up of their breathing problem.
For companies in the medical devices sector, this recent outburst in the incidence of COPD presents a good opportunity to plan for market entry and take advantage of the emerging high demand for various treatment options. However, entering a market space that is rapidly becoming competitive is no simple feat due to the limited availability of statistical information and prevalence rate for COPD. Also, the lack of concrete information on the price-rate variation for COPD and NIV treatment will pose a significant challenge for most medical devices manufacturers looking to enter or expand their market share in this space.
The Business Challenge
To assess the changing demand-supply landscape of the COPD and NIV treatment market across Europe, a leading global respiratory device manufacturer approached Infiniti to obtain effective healthcare information mapping and insights on emerging and untapped market opportunities which they can target.
The primary goal of this market opportunity assessment and healthcare information mapping engagement was to evaluate the prevalence and magnitude of COPD and global initiative for chronic obstructive lung disease (GOLD) across 10 European countries. Additionally, the healthcare information mapping service also offered insights on popular treatment patterns to assess the potential for their devices across a specific set of target countries such as the UK, France, Italy, Germany, Spain, Sweden, Norway, Switzerland, Denmark, Portugal, and Finland.
Infiniti’s experienced healthcare information mapping and market opportunity assessment team tracked recent developments and innovations in the market through secondary journals and reached out to relevant stakeholders such as industry experts, KOLs, device users, procurement experts to understand their views on the market. Our healthcare information mapping and market opportunity assessment research team also spoke to stakeholders responsible for sales and distribution of these devices to understand how the market would grow in short and long term and also to validate market size and opportunity model developed for this segment.
The Business Solution Offered and Impac
By evaluating a wide array of published literature to develop an initial hypothesis, Infiniti’s industry experts identified numerous market stakeholders and conducted in-depth primary and secondary research to determine the prevalence, prescription patterns, key treatment methods used, and new trends affecting the COPD treatment in Europe. The research team also conducted a large number of interviews and discussions with major market stakeholders to obtain information specific to the market.
In just eight weeks, our healthcare experts helped the client gain strategic insights into the prevalence of COPD and GOLD in Europe along with an analysis of the latest developments and innovations in this space.
To assess the challenges specific to the healthcare medical devices sector, Infiniti’s healthcare experts have developed an extensive proprietary database consisting of information on more than two million industry experts, doctors, physicians, key opinion leaders, medical technicians, payers, end-users, and patients. This database also includes high quality and accurate information obtained through quantitative and qualitative surveys with effective response rate. We also have a collection of the best-in-class global network of 3000+ payers’ influencers, and KOLs spread across multiple channels in 50+ countries.